Cargando…
Identification of Drivers from Cancer Genome Diversity in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with a dismal outcome. The complicated molecular pathogenesis of HCC caused by tumor heterogeneity makes it difficult to identify druggable targets useful for treating HCC patients. One approach that has a potential for the improvement...
Autores principales: | Takai, Atsushi, Dang, Hien T., Wang, Xin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100204/ https://www.ncbi.nlm.nih.gov/pubmed/24955791 http://dx.doi.org/10.3390/ijms150611142 |
Ejemplares similares
-
Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma
por: Takai, Atsushi, et al.
Publicado: (2016) -
Integrative Genomics Identifies YY1AP1 as an Oncogenic Driver in EpCAM(+) AFP(+) Hepatocellular Carcinoma
por: Zhao, Xuelian, et al.
Publicado: (2015) -
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022) -
Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
por: Patel, Keyur, et al.
Publicado: (2020) -
Identification of Driver Genes Regulating the T-Cell–Infiltrating Levels in Hepatocellular Carcinoma
por: Cai, Yi, et al.
Publicado: (2020)